David Thompson

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

Rasha Al‐Lamee, David Thompson, Hakim‐Moulay Dehbi et al. · The Lancet · 2017 · 975 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

Diabetes and Pregnancy

David Thompson, Howard Berger, Denice S. Feig et al. · Canadian Journal of Diabetes · 2013 · 375 citations

Infertility, Diabetes, Gynecology +8

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

Ajay Gupta, David Thompson, Andrew Whitehouse et al. · The Lancet · 2017 · 333 citations · Full text

Adverse Events, Cardiovascular Disease, Clinical Trials +8

Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes

Adam Ramzy, David Thompson, Kirsten A. Ward‐Hartstonge et al. · Cell stem cell · 2021 · 307 citations

Regenerative Medicine, Type 1, Medicine +7

Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device

A. M. James Shapiro, David Thompson, Thomas Donner et al. · Cell Reports Medicine · 2021 · 284 citations · Full text

Tissue Engineering, Engineering, Immunology +18